Search - tctmd.com

Displaying 421 - 440 of 448

Sort: Relevancy | Date

News Daily News

Endovascular Therapy Promising for Critical Limb Ischemia

L.A. McKeown

February 07, 2013

Presentation TCT 2013

Familial Hypercholesterolemic Swine In-Stent Restenosis Model, But Not Contemporaneous Injury+Treatment Model, Predicts Efficacy of Drug Coated Balloon in Peripheral Arteries

Presenter: Maxwell Afari, Armando Tellez, Yanping Cheng, Seung-Jin Oh, Piotr Buszman, Krzysztof Milewski, Jong Shiuan Yeh, Juan Granada, Greg Kaluza

January 31, 2013

News Daily News

Self-Expanding Nitinol Stent Potential Option in Popliteal Artery Disease

January 24, 2013

News Daily News

PACIFIER Published: Drug-Eluting Balloon Helps Treat Femoropopliteal Lesions

Caitlin E. Cox

December 09, 2012

News Conference News TCT 2012

ETAP Trial: Nitinol Stent Bests Angioplasty for Popliteal Artery Disease

November 18, 2012

News Daily News

BELLO: Drug-Coated Balloons Take on De Novo Lesions vs. DES

Caitlin E. Cox

November 15, 2012

Presentation TCT 2012

SEDUCE: A Prospective, Randomized Trial of Drug Coated Balloon vs. Everolimus-Eluting Stent in for BMS Restenosis: Optical Coherence Tomography Assessment

Presenter: Tom Adriaenssens

October 25, 2012

Presentation TCT 2012

Drug-Coated Balloons for SFA In-Stent Restenosis: A Simple Solution for a Tenacious Problem?

Presenter: Eugenio Stabile

October 22, 2012

News Industry News

IDEV Presents Consistent Evidence Validating the Mimetic Design of SUPERA® Stent

October 22, 2012

News Industry News

Vascular Nanotransfer Technologies (“VNT”) reports in vivo results for its paclitaxel nano-carrier based drug coated balloon (DCB) technology

October 19, 2012

News Daily News

Meta-analysis: Paclitaxel-Coated Balloon Reduces TLR in Femoropopliteal Disease

August 07, 2012

News Daily News

Drug-Eluting Balloon Continues Strong Showing in SFA Lesions

Jason Kahn

March 22, 2012

News Daily News

PEPCAD-DES: Paclitaxel-Coated Balloon Bests Plain Balloon for DES Restenosis

March 05, 2012

Presentation ISET 2012

Drug-coated Balloons and Stents in the Periphery: Is There a Future?

Presenter: Ron Waksman

January 15, 2012

News Conference News

PEPCAD-DES: Drug-Coated Balloon Better Than Uncoated Balloon for DES Restenosis

November 27, 2011

News Industry News

Paclitaxel-coated balloon angioplasty demonstrates superior results

November 10, 2011

News Industry News

Bayer HealthCare's Cotavance Drug Eluting Balloon With Paccocath Technology Reduced Five-Year Target Lesion Revascularization Rates

November 09, 2011

News Conference News

PAX Studies Highlight Polymer-Free DES Success

November 07, 2011

News Industry News

Medtronic’s Unmatched Portfolio of Cardiovascular Devices Features Prominently on Program for TCT 2011

November 04, 2011

News Industry News

Bayer HealthCare's MEDRAD Interventional Business Announces Five-Year Data of Cotavance® Drug Eluting Balloon with Paccocath® Technology to be Presented at 2011 TCT

November 03, 2011

Advertisement

Endovascular Therapy Promising for Critical Limb Ischemia

Familial Hypercholesterolemic Swine In-Stent Restenosis Model, But Not Contemporaneous Injury+Treatment Model, Predicts Efficacy of Drug Coated Balloon in Peripheral Arteries

Self-Expanding Nitinol Stent Potential Option in Popliteal Artery Disease

PACIFIER Published: Drug-Eluting Balloon Helps Treat Femoropopliteal Lesions

ETAP Trial: Nitinol Stent Bests Angioplasty for Popliteal Artery Disease

BELLO: Drug-Coated Balloons Take on De Novo Lesions vs. DES

SEDUCE: A Prospective, Randomized Trial of Drug Coated Balloon vs. Everolimus-Eluting Stent in for BMS Restenosis: Optical Coherence Tomography Assessment

Drug-Coated Balloons for SFA In-Stent Restenosis: A Simple Solution for a Tenacious Problem?

IDEV Presents Consistent Evidence Validating the Mimetic Design of SUPERA® Stent

Vascular Nanotransfer Technologies (“VNT”) reports in vivo results for its paclitaxel nano-carrier based drug coated balloon (DCB) technology

Meta-analysis: Paclitaxel-Coated Balloon Reduces TLR in Femoropopliteal Disease

Drug-Eluting Balloon Continues Strong Showing in SFA Lesions

PEPCAD-DES: Paclitaxel-Coated Balloon Bests Plain Balloon for DES Restenosis

Drug-coated Balloons and Stents in the Periphery: Is There a Future?

PEPCAD-DES: Drug-Coated Balloon Better Than Uncoated Balloon for DES Restenosis

Paclitaxel-coated balloon angioplasty demonstrates superior results

Bayer HealthCare's Cotavance Drug Eluting Balloon With Paccocath Technology Reduced Five-Year Target Lesion Revascularization Rates

PAX Studies Highlight Polymer-Free DES Success

Medtronic’s Unmatched Portfolio of Cardiovascular Devices Features Prominently on Program for TCT 2011

Bayer HealthCare's MEDRAD Interventional Business Announces Five-Year Data of Cotavance® Drug Eluting Balloon with Paccocath® Technology to be Presented at 2011 TCT

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content